Page last updated: 2024-09-04

bazedoxifene and Uterine Cervical Neoplasms

bazedoxifene has been researched along with Uterine Cervical Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Heo, TH; Kim, H; Kim, L; Park, H; Park, SA	1

Other Studies

1 other study(ies) available for bazedoxifene and Uterine Cervical Neoplasms

Article	Year
Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer. International journal of molecular sciences, 2021, Aug-13, Volume: 22, Issue:16 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokine Receptor gp130; Drug Repositioning; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Humans; Indoles; Interleukin-6; Mice; Mice, Nude; Papillomavirus Infections; Phosphorylation; Protein Interaction Maps; Signal Transduction; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2021

Article

Year

Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer.

International journal of molecular sciences, 2021, Aug-13, Volume: 22, Issue:16

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokine Receptor gp130; Drug Repositioning; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Humans; Indoles; Interleukin-6; Mice; Mice, Nude; Papillomavirus Infections; Phosphorylation; Protein Interaction Maps; Signal Transduction; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2021